Overview

Effects of Ketamine in the Acute Phase of Suicidal Ideation

Status:
Completed
Trial end date:
2019-03-26
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the efficacy of ketamine versus a placebo for the short-term (at 72h, i.e. 24h after the last perfusion) relief of suicidal ideation, measured using the BSS hetero questionnaire, in patients hospitalized for suicide risk.
Phase:
Phase 3
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Treatments:
Ketamine